Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cancer Treatment Reviews | journal | 3.420 Q1 | 164 | 129 | 342 | 11613 | 3175 | 340 | 8.70 | 90.02 | 41.85 | |
2 | Nature Reviews Cancer | journal | 23.530 Q1 | 505 | 121 | 389 | 10019 | 8088 | 197 | 21.57 | 82.80 | 33.20 | |
3 | Expert Review of Anticancer Therapy | journal | 0.804 Q2 | 85 | 120 | 430 | 8365 | 856 | 403 | 2.10 | 69.71 | 34.73 | |
4 | Molecular Cancer | journal | 2.778 Q1 | 196 | 170 | 537 | 11444 | 4078 | 533 | 8.00 | 67.32 | 41.41 | |
5 | npj Precision Oncology | journal | 36 | 1 | 0 | 67 | 0 | 0 | 0.00 | 67.00 | 25.00 | ||
6 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 4 | 0 | 241 | 0 | 0 | 0.00 | 60.25 | 40.00 | ||
7 | European Oncology and Haematology | journal | 0.137 Q4 | 8 | 21 | 70 | 1209 | 13 | 50 | 0.16 | 57.57 | 44.00 | |
8 | Best Practice and Research in Clinical Haematology | journal | 1.260 Q2 | 81 | 45 | 112 | 2554 | 258 | 105 | 2.04 | 56.76 | 41.67 | |
9 | Journal of Hematology and Oncology | journal | 2.292 Q1 | 144 | 170 | 347 | 9485 | 2340 | 343 | 7.26 | 55.79 | 42.48 | |
10 | Immunotherapy | journal | 0.986 Q2 | 65 | 135 | 368 | 7433 | 979 | 345 | 2.77 | 55.06 | 36.89 | |
11 | Molecular Therapy - Oncolytics | journal | 1.193 Q2 | 42 | 34 | 66 | 1695 | 241 | 64 | 3.87 | 49.85 | 39.01 | |
12 | Endocrine-Related Cancer | journal | 2.118 Q1 | 146 | 124 | 418 | 6107 | 2281 | 392 | 5.08 | 49.25 | 42.94 | |
13 | Infectious Agents and Cancer | journal | 0.855 Q2 | 47 | 56 | 148 | 2651 | 364 | 147 | 2.55 | 47.34 | 45.78 | |
14 | Journal of Experimental and Clinical Cancer Research | journal | 2.000 Q1 | 120 | 178 | 425 | 7896 | 2557 | 425 | 6.20 | 44.36 | 42.45 | |
15 | Breast Cancer Research | journal | 3.026 Q1 | 175 | 123 | 472 | 5441 | 3112 | 447 | 6.16 | 44.24 | 48.69 | |
16 | Hereditary Cancer in Clinical Practice | journal | 0.848 Q2 | 31 | 20 | 56 | 878 | 136 | 53 | 2.43 | 43.90 | 55.36 | |
17 | Cancer Cell International | journal | 1.130 Q2 | 80 | 117 | 340 | 5101 | 1198 | 340 | 3.95 | 43.60 | 40.98 | |
18 | European Journal of Cancer Care | journal | 0.849 Q2 | 78 | 231 | 301 | 9700 | 585 | 262 | 1.71 | 41.99 | 56.92 | |
19 | Journal of Geriatric Oncology | journal | 1.259 Q2 | 53 | 73 | 190 | 3056 | 619 | 174 | 3.23 | 41.86 | 47.12 | |
20 | npj Breast Cancer | journal | 46 | 48 | 40 | 2007 | 146 | 37 | 3.65 | 41.81 | 50.68 | ||
21 | Journal of Ovarian Research | journal | 1.008 Q2 | 61 | 77 | 277 | 3175 | 780 | 275 | 2.65 | 41.23 | 51.84 | |
22 | Future Oncology | journal | 0.759 Q3 | 90 | 312 | 951 | 12756 | 1848 | 844 | 1.84 | 40.88 | 38.29 | |
23 | Journal for ImmunoTherapy of Cancer | journal | 2.798 Q1 | 117 | 96 | 215 | 3910 | 1320 | 193 | 5.88 | 40.73 | 39.53 | |
24 | Experimental Hematology and Oncology | journal | 0.842 Q2 | 42 | 32 | 93 | 1249 | 247 | 90 | 2.98 | 39.03 | 41.75 | |
25 | Cancer Medicine | journal | 1.470 Q1 | 84 | 285 | 731 | 11121 | 2608 | 723 | 3.44 | 39.02 | 37.09 | |
26 | BMC Cancer | journal | 1.464 Q1 | 160 | 891 | 2934 | 33372 | 11004 | 2932 | 3.50 | 37.45 | 40.59 | |
27 | British Journal of Cancer | journal | 2.890 Q1 | 272 | 432 | 1576 | 16098 | 9826 | 1465 | 5.92 | 37.26 | 43.28 | |
28 | ecancermedicalscience | journal | 0.688 Q3 | 47 | 84 | 332 | 3097 | 560 | 332 | 1.79 | 36.87 | 37.67 | |
29 | European Journal of Surgical Oncology | journal | 1.466 Q1 | 117 | 308 | 789 | 11005 | 2848 | 708 | 3.58 | 35.73 | 29.99 | |
30 | Prostate Cancer and Prostatic Diseases | journal | 2.149 Q1 | 78 | 66 | 175 | 2354 | 809 | 175 | 4.61 | 35.67 | 25.37 | |
31 | Leukemia | journal | 5.131 Q1 | 219 | 397 | 1065 | 14079 | 7393 | 643 | 6.33 | 35.46 | 36.90 | |
32 | Cancer Communications | journal | 79 | 55 | 253 | 1939 | 916 | 231 | 3.47 | 35.25 | 37.37 | ||
33 | Cancer Treatment and Research Communications | journal | 0.250 Q3 | 23 | 29 | 117 | 1022 | 54 | 117 | 0.43 | 35.24 | 32.56 | |
34 | Leukemia Research | journal | 1.063 Q2 | 96 | 185 | 645 | 6493 | 1459 | 591 | 2.23 | 35.10 | 45.29 | |
35 | Psycho-Oncology | journal | 1.667 Q1 | 158 | 314 | 637 | 10929 | 2199 | 571 | 3.01 | 34.81 | 59.00 | |
36 | European Journal of Cancer | journal | 2.963 Q1 | 245 | 456 | 1041 | 15856 | 6615 | 963 | 6.52 | 34.77 | 41.57 | |
37 | Oral Oncology | journal | 1.912 Q1 | 137 | 282 | 657 | 9751 | 2589 | 527 | 3.95 | 34.58 | 34.91 | |
38 | Radiation Oncology | journal | 1.293 Q2 | 91 | 204 | 723 | 6960 | 2306 | 717 | 3.10 | 34.12 | 29.67 | |
39 | Cardio-Oncology | journal | 21 | 7 | 15 | 237 | 32 | 14 | 2.13 | 33.86 | 39.39 | ||
40 | Neuro-Oncology | journal | 4.064 Q1 | 163 | 216 | 642 | 7227 | 4716 | 522 | 7.14 | 33.46 | 37.25 | |
41 | Nature Reviews Clinical Oncology | journal | 6.541 Q1 | 217 | 216 | 547 | 7105 | 3661 | 259 | 6.78 | 32.89 | 26.62 | |
42 | Pigment Cell and Melanoma Research | journal | 2.120 Q1 | 120 | 72 | 329 | 2355 | 1156 | 225 | 3.67 | 32.71 | 46.67 | |
43 | Clinical Oncology | journal | 1.216 Q2 | 89 | 161 | 413 | 5051 | 939 | 265 | 2.20 | 31.37 | 34.82 | |
44 | Journal of Cancer Policy | journal | 0.459 Q3 | 20 | 48 | 62 | 1500 | 58 | 55 | 0.67 | 31.25 | 35.37 | |
45 | Pediatric Hematology and Oncology | journal | 0.462 Q3 | 48 | 52 | 229 | 1611 | 267 | 200 | 1.17 | 30.98 | 47.47 | |
46 | ESMO Open | journal | 60 | 94 | 96 | 2897 | 262 | 73 | 2.73 | 30.82 | 34.89 | ||
47 | Journal of Chemotherapy | journal | 0.483 Q3 | 56 | 70 | 234 | 2058 | 296 | 214 | 1.27 | 29.40 | 39.84 | |
48 | Journal of the National Cancer Institute | journal | 5.488 Q1 | 387 | 271 | 988 | 7820 | 5836 | 542 | 5.69 | 28.86 | 40.82 | |
49 | Cancer Imaging | journal | 1.012 Q2 | 64 | 30 | 108 | 859 | 344 | 104 | 3.23 | 28.63 | 28.10 | |
50 | Leukemia and Lymphoma | journal | 0.976 Q2 | 102 | 453 | 1633 | 12825 | 2588 | 1000 | 1.53 | 28.31 | 43.60 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®